A 51-year-old patient from the Maldives with a 2 cm renal tumour, deemed too high-risk for traditional surgical removal due to cardiac co-morbidities, has successfully recovered and returned to normal life after undergoing a minimally invasive cryoablation procedure at KIMSHEALTH in Thiruvananthapuram. This "Freeze Technology" utilizes specialized needles to deliver extreme cold, in this case, argon gas, to create an ice ball around the tumour, effectively destroying abnormal tissue while preserving the surrounding healthy kidney, demonstrating the growing efficacy of organ-preserving and minimally invasive treatment methodologies.

A 51-year-old patient from the Maldives with a 2 cm renal tumour, deemed too high-risk for traditional surgical removal due to cardiac co-morbidities, has successfully recovered and returned to normal life after undergoing a minimally invasive cryoablation procedure at KIMSHEALTH in Thiruvananthapuram. This "Freeze Technology" utilizes specialized needles to deliver extreme cold, in this case, argon gas, to create an ice ball around the tumour, effectively destroying abnormal tissue while preserving the surrounding healthy kidney, demonstrating the growing efficacy of organ-preserving and minimally invasive treatment methodologies.

A 51-year-old patient from the Maldives with a 2 cm renal tumour, deemed too high-risk for traditional surgical removal due to cardiac co-morbidities, has successfully recovered and returned to normal life after undergoing a minimally invasive cryoablation procedure at KIMSHEALTH in Thiruvananthapuram. This "Freeze Technology" utilizes specialized needles to deliver extreme cold, in this case, argon gas, to create an ice ball around the tumour, effectively destroying abnormal tissue while preserving the surrounding healthy kidney, demonstrating the growing efficacy of organ-preserving and minimally invasive treatment methodologies.

A 51-year-old patient from the Maldives, diagnosed with a renal tumour, has returned to normal life following a successful, minimally invasive cryoablation procedure—popularly known as 'Freeze Technology'. 

What is 'freeze technology'? 

Cryoablation is a minimally invasive procedure that uses extreme cold (such as liquid nitrogen or argon gas) to freeze and destroy targeted abnormal tissue, tumours, or nerves. It is widely used in oncology, cardiology, and pain management. 

The patient, diagnosed with a 2 cm tumour in the right kidney, was referred to KIMSHEALTH, Thiruvanathapuram, for further management. Usually, such tumours are removed surgically, but, given his significant cardiac co-morbidities, surgical removal of the tumour posed a high risk. 

After evaluating the patient's condition, the medical team led by Dr Manish Kumar Yadav, Senior Consultant, Neuro Interventional Radiology, KIMSHEALTH, opted to perform cryoablation, as the safest and most effective alternative.

How does 'freeze technology' work? 

During the procedure, specialised needles were precisely placed into the tumour under image guidance. Argon gas was then circulated through these needles to reduce the temperature within the tumour to sub-freezing levels, thereby creating an 'ice ball' around the lesion, to destroy the tumour cells, while preserving the surrounding healthy kidney tissue. 

“The success of this procedure underscores the growing importance of organ-preserving and minimally invasive treatment methodology. Through cryoablation, we were able to effectively treat the tumour while preserving the kidney and its functions, ensuring a faster recovery for the patient,” said Dr Yadav.

According to the doctors, the patient was discharged after three days of hospital stay and is now back to his normal routine. Dr Santhosh Joseph, Senior Consultant, Neuro Interventional Radiology and Dr Sarath Surendran, Associate Consultant, Neuro Anaesthesia, were also part of the hour-long procedure.